The relationship between migraine and right-to-left shunt: Fact or fiction?

Chest

Volumn 130, Issue 3, 2006, Pages 896-901

  Post, Martijn C ^a   Budts, Werner ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Arteriovenous malformation; Atrial septal defect; Migraine; Patent foramen ovale; Shunt

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ARTERIOVENOUS MALFORMATION; DISEASE ASSOCIATION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT LEFT SHUNT; LOW DRUG DOSE; LUNG ARTERIOVENOUS SHUNT; MIGRAINE; MIGRAINE WITH AURA; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SHUNTING;

EID: 33748852398     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.896     Document Type: Article

References (50)

1. Silberstein SD. Migraine. Lancet 2004; 363:381-391
2. Rapoport A, Edmeads J. Migraine: the evolution of our knowledge. Arch Neurol 2000; 57:1221-1223
3. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8:327-330
4. Sztajzel R, Genoud D, Roth S, et al. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002; 13:102-106
5. The international classification of headache disorders: 2nd edition. Cephalalgia 2004; 24(suppl):9-160
6. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990; 28:791-798
7. Ramadan NM. Targeting therapy for migraine: what to treat? Neurology 2005; 64:S4-S8
8. Olesen J, Tfelt-Hansen P, Henriksen L, et al. The common migraine attack may not be initiated by cerebral ischaemia. Lancet 1981; 2:438-440
9. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994; 44:S17-S23
10. Lusic I. Population variation in migraine prevalence: the unsolved problem. Coll Antropol 2001; 25:695-701
11. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984; 59:17-20
12. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55:1172-1179
13. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54:714-729
14. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91:66-67
15. Westermann CJ, Rosina AF, De Vries V, et al. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet 2003; 116:324-328
16. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245:31-39
17. Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32:877-882
18. Campbell M. Natural history of atrial septal defect. Br Heart J 1970; 32:820-826
19. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults: first of two parts. N Engl J Med 2000; 342:256-263
20. Craig RJ, Selzer A. Natural history and prognosis of atrial septal defect. Circulation 1968; 37:805-815
21. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999; 52:1622-1625
22. Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005; 65:1415-1418
23. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100:215-220
24. Post MC, Thijs V, Herroelen L, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004; 62:1439-1440
25. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62:1399-1401
26. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005; 45:493-495
27. Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55:959-964
28. White RI Jr., Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169:663-669
29. Post MC, Letteboer TG, Mager JJ, et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005; 128:2485-2489
30. Mortelmans K, Post M, Thijs V, et al. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005; 26:1533-1537
31. Azarbal B, Tobis J, Suh W, et al. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol 2005; 45:489-492
32. Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356:1648-1651
33. Morandi E, Anzola GP, Angeli S, et al. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16:39-42
34. Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2005; 37:430-434
35. Post MC, Thijs V, Schonewille WJ, et al. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006; 66:202-205
36. Yankovsky AE, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003; 43:496-498
37. Gorji A, Scheller D, Straub H, et al. Spreading depression in human neocortical slices. Brain Res 2001; 906:74-83
38. Silberstein SD. Migraine pathophysiology and its clinical implications. Cephalalgia 2004; 24(suppl):2-7
39. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004; 43:302-309
40. Lipton RB, Goldstein J, Baggish JS, et al. Aspirin is efficacious for the treatment of acute migraine. Headache 2005; 45:283-292
41. Bensenor IM, Cook NR, Lee IM, et al. Low-dose aspirin for migraine prophylaxis in women. Cephalalgia 2001; 21:175-183
42. Anzola GP, Frisoni GB, Morandi E, et al. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006; 37:430-434
43. van der Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002; 22:265-270
44. Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005; 330:63-65
45. Zeller JA, Frahm K, Baron R, et al. Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry 2004; 75:984-987
46. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427-434
47. Venketasubramanian N, Sacco RL, Di Tullio M, et al. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993; 43:1533-1535
48. Fragoso YD. Reduction of migraine attacks during the use of warfarin. Headache 1997; 37:667-668
49. Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90:1315-1320
50. Muta H, Ishii M, Maeno Y, et al. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002; 91:649-652